Performance
Tirzepatide
GIP/GLP-1 Dual Agonist
Batch-verified. Current lot TRZ-2196-E8 — third-party HPLC & LC-MS tested.
View Certificate of Analysis →
Coming Soon
Tirzepatide is a dual agonist of the GIP and GLP-1 receptors, studied in metabolic research for combined incretin-pathway activity in weight-regulation and glycemic-control models.
- Dual GIP/GLP-1 receptor agonist
- Studied in combined incretin-pathway research
- Focus of current metabolic literature
- Well-documented comparative studies
Research Use Only. This product is sold for laboratory research purposes only and is not intended for human or veterinary use. Descriptions reference published research and do not constitute claims of efficacy or medical advice.